| scholarly article | Q13442814 |
| P50 | author | Diego A Vargas-Inchaustegui | Q88258281 |
| Marjorie Robert-Guroff | Q30651738 | ||
| Iskra Tuero | Q30651764 | ||
| P2093 | author name string | Peng Xiao | |
| L Jean Patterson | |||
| P2860 | cites work | Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection | Q37206430 |
| Functionally distinct NK-cell subsets: developmental origins and biological implications | Q37315676 | ||
| Genetic determinants of HIV-1 infection and progression to AIDS: immune response genes | Q37599963 | ||
| T cell immunity in acute HIV-1 infection. | Q37789345 | ||
| Interleukin-22: A cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection | Q37792615 | ||
| Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). | Q37854081 | ||
| Induction of innate immunity in control of mucosal transmission of HIV. | Q37898467 | ||
| NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination | Q39077343 | ||
| Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes | Q39077351 | ||
| T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus | Q40480541 | ||
| HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome | Q41937295 | ||
| Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein | Q42117244 | ||
| A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities | Q43743967 | ||
| HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. | Q43787461 | ||
| Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum | Q47965455 | ||
| Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C/C2 expression. | Q54587667 | ||
| CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity | Q57265370 | ||
| CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset | Q68440922 | ||
| Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells | Q79667542 | ||
| Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation | Q81180148 | ||
| Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection | Q81669570 | ||
| The use of nonhuman primate models in HIV vaccine development | Q21563403 | ||
| Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22 | Q24655076 | ||
| Innate or adaptive immunity? The example of natural killer cells | Q29615106 | ||
| CD8(+)T-cell-mediated control of HIV-1 and SIV infection | Q30397667 | ||
| Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state | Q30435854 | ||
| Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals | Q33864775 | ||
| CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection | Q33896743 | ||
| Impact of MHC class I diversity on immune control of immunodeficiency virus replication | Q34235198 | ||
| The biology of human natural killer-cell subsets | Q34430869 | ||
| Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge | Q34574409 | ||
| Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection | Q34694776 | ||
| Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection | Q34764016 | ||
| Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys | Q35077793 | ||
| Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers | Q35077809 | ||
| Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection | Q35230224 | ||
| Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques | Q35484743 | ||
| Innate immunity in acute HIV-1 infection | Q35696991 | ||
| Dendritic cells and natural killer cells in the pathogenesis of HIV infection | Q36240105 | ||
| The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers | Q36424504 | ||
| Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication | Q36483278 | ||
| Natural killer cells as an initial defense against pathogens | Q36502291 | ||
| Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting | Q36954239 | ||
| Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection | Q36961218 | ||
| Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys | Q37032170 | ||
| Expanding roles for CD4⁺ T cells in immunity to viruses. | Q37150560 | ||
| Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease | Q37189179 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Macaca | Q177601 |
| Simian immunodeficiency virus | Q1890246 | ||
| P304 | page(s) | 1878-1885 | |
| P577 | publication date | 2012-07-13 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model | |
| P478 | volume | 189 |
| Q35760504 | 2B4 Is Dispensable for T-Dependent B Cell Immune Responses, but Its Deficiency Leads to Enhanced T-Independent Responses Due to an Increase in Peritoneal Cavity B1b Cells. |
| Q38234942 | Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV. |
| Q34057778 | CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination |
| Q34364695 | Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. |
| Q42257677 | Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention |
| Q38777407 | Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases. |
| Q89207371 | Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells |
| Q36086345 | Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat |
| Q38491184 | Innate immunity against HIV-1 infection |
| Q36957775 | Mucosal immunology of HIV infection |
| Q90290714 | NK Cell Precursors in Human Bone Marrow in Health and Inflammation |
| Q34700499 | NK cells and their ability to modulate T cells during virus infections |
| Q39041518 | NK cells in host responses to viral infections |
| Q41930380 | Phenotypic and Functional Characterization of Circulatory, Splenic, and Hepatic NK Cells in Simian Immunodeficiency Virus-Controlling Macaques. |
| Q36231936 | Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine |
| Q33763297 | Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response |
| Q41519074 | Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques |
| Q35861190 | Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection |
| Q41926409 | Yellow fever virus, but not Zika or Dengue virus inhibits T cell receptor-mediated T cell function by an RNA-based mechanism |
Search more.